Pharmaceuticals, Biotechnology and Life Sciences
Scientists from UK-headquartered AI precision medicine company, PrecisionLife, have found 68 genes associated with risk of developing severe COVID-19 by using its proprietary AI-enabled precision medicine platform to analyze the genomes of 929 patients from the UK Biobank who had a severe response to SARS-CoV-2.
Two Randomized Double-Blind Placebo Controlled Studies In COVID-19 Patients Follow Phase 1 Trials Showing Safety & Promising Exposures in Humans…
Vyripharm Biopharmaceuticals and Regis Technologies, Inc. Have Signed Off on a Master Drug Program Agreement for Expediting cGMP Manufacture of Our Antiviral Agents for Diagnostic Evaluation of COVID-19.
LONDON–(BUSINESS WIRE)–#Analytics–One of the world’s leading analytics solutions provider, Quantzig, announces the completion of its recent article that presents comprehensive…
Eurofins Technologies (Paris:ERF) announces the launch of a serology-based total antibody (IgG, IgA and IgM) detection ELISA assay for indirect diagnostic of past exposure to COVID-19.
LONDON–(BUSINESS WIRE)–#AlprazolamMarket–The alprazolam market is poised to grow by USD 90.33 million during 2020-2024, progressing at a CAGR of over…
FDA allowed FSD Pharma to submit an Investigational New Drug Application (IND) for the use of FSD-201 to treat COVID-19, the disease caused by the SARS-CoV-2 virus.
CordenPharma has announced Tuesday its extended agreement with Moderna in its supply of lipids to support the development of Coronavirus Vaccine.
Bioparticle-based delivery system offers potential as a coronavirus therapy LOS ANGELES–(BUSINESS WIRE)–An emerging company developing biotechnology invented at UCLA is…
BETHESDA, Md. & AUSTIN, Texas–(BUSINESS WIRE)–Longhorn Vaccines & Diagnostics, an innovative molecular tool, assay and vaccine development company focused on…